NO | उत्पादों | CAS संख्या | प्रमुख गुणवत्ता संकेतक | |||
पवित्रता | मैक्स। अपवित्रता | कुल विलायक अवशेष | नमी | |||
1 | Fmoc-β-अला-अला-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
2 | Fmoc-D-Ala-D-Ala-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
3 | Fmoc-β-Ala-D-Ala-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
4 | Fmoc-Arg(pbf)-Arg(pbf)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
5 | Fmoc-β-Ala-Arg(pbf)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
6 | Fmoc-D-Arg(pbf)-D-Arg(pbf)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
7 | Fmoc-β-Ala-D-Arg(pbf)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
8 | Fmoc-HomoArg(pbf)-HomoArg(pbf)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
9 | Fmoc-β-Ala-HomoArg(pbf)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
10 | Fmoc-Asn(Trt)-Asn(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
11 | Fmoc-β-Ala-Asn(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
12 | Fmoc-Asp(OtBu)-Asp(OtBu)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
13 | Fmoc-β-Ala-Asp(OtBu)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
14 | Fmoc-Cys(Trt)-Cys(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
15 | Fmoc-β-Ala-Cys(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
16 | Fmoc-Cys(Acm)-Cys(Acm)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
17 | Fmoc-β-Ala-Cys(Acm)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
18 | Fmoc-Gln(Trt)-Gln(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
19 | Fmoc-β-Ala-Gln(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
20 | Fmoc-Glu(OtBu)-Glu(OtBu)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
21 | Fmoc-β-Ala-Glu(OtBu)-OH.H2O | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
22 | Fmoc-β-Ala-Gly-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
23 | Fmoc-His(Trt)-His(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
24 | Fmoc-β-Ala-His(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
25 | Fmoc-Ile-Ile-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
26 | Fmoc-β-Ala-Ile-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
27 | Fmoc-Leu-Leu-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
28 | Fmoc-β-Ala-Leu-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
29 | Fmoc-D-Leu-D-Leu-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
30 | Fmoc-β-Ala-D-Leu-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
31 | Fmoc-Lys(Boc)-Lys(Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
32 | Fmoc-β-Ala-Lys(Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
33 | Fmoc-Lys(Alloc)-Lys(Alloc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
34 | Fmoc-β-Ala-Lys(Alloc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
35 | एफएमओसी-मेट-मेट-ओएच | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
36 | Fmoc-β-Ala-Met-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
37 | Fmoc-Orn(Boc)-Orn(Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
38 | Fmoc-β-Ala-Orn(Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
39 | Fmoc-Phe-Phe-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
40 | Fmoc-β-Ala-Phe-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
41 | Fmoc-D-Phe-D-Phe-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
42 | Fmoc-β-Ala-D-Phe-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
43 | एफएमओसी-प्रो-प्रो-ओएच | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
44 | Fmoc-β-Ala-Pro-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
45 | Fmoc-Ser(tBu)-Ser(tBu)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
46 | Fmoc-β-Ala-Ser(tBu)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
47 | Fmoc-Ser(Trt)-Ser(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
48 | Fmoc-β-Ala-Ser(Trt)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
49 | Fmoc-Thr(tBu)-Thr(tBu)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
50 | Fmoc-β-Ala-Thr(tBu)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
51 | Fmoc-Trp(Boc)-Trp(Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
52 | Fmoc-β-Ala-Trp(Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
53 | Fmoc-D-Trp(Boc)-D-Trp(Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
54 | Fmoc-β-Ala-D-Trp(Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
55 | Fmoc-Tyr(tBu)-Tyr(tBu)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
56 | Fmoc-β-Ala-Tyr(tBu)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
57 | Fmoc-D-Tyr(Et)-D-Tyr(Et)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
58 | Fmoc-β-Ala-D-Tyr(Et)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
59 | Fmoc-Tyr(Me)-Tyr(Me)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
60 | Fmoc-β-Ala-Tyr(Me)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
61 | Fmoc-वैल-वैल-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
62 | Fmoc-β-Ala-Val-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
63 | Fmoc-D-Cit-D-Cit-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
64 | Fmoc-β-Ala-D-Cit-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
65 | Fmoc-β-Ala-Dab-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
66 | Fmoc-(3-(2-naphthyl)-D-Ala)2-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
67 | Fmoc-β-Ala-3-(2-naphthyl)-D-Ala-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
68 | Fmoc-(3-(3-pyridinyl)-D-Ala)2-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
69 | Fmoc-β-Ala-3-(3-pyridinyl)-D-Ala-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
70 | Fmoc-(4-क्लोरो-डी-फे)2-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
71 | Fmoc-β-Ala-4-chloro-D-Phe-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
72 | Fmoc-(D-4Aph(tBuCbm))2-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
73 | Fmoc-β-Ala-D-4Aph (tBuCbm)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
74 | Fmoc-Aph(L-Hor)-Aph(L-Hor)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
75 | Fmoc-β-Ala-Aph(L-Hor)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
76 | Fmoc-Lys(iPr,Boc)-Lys(iPr,Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
77 | Fmoc-β-Ala-Lys(iPr,Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
78 | Fmoc-β-Ala-AEEA-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
79 | Fmoc-ऐब-ऐब-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
80 | Fmoc-β-Ala-Aib-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
81 | Fmoc-Arg-OH | 91000-69-0 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
82 | एच-आर्ग (पीबीएफ) -ओएच | 200115-86-2 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
83 | Fmoc-D-Arg-OH | 130752-32-8 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
84 | एचडी-आर्ग (पीबीएफ) -ओएच | 200116-81-0 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
85 | Fmoc-HomoArg-OH.HCl | 208174-14-5 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
86 | एच-होमोआर्ग (पीबीएफ)-ओएच | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
87 | Fmoc-D-HomoArg-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
88 | एचडी-होमोआर्ग (पीबीएफ)-ओएच | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
89 | Fmoc-Asn-OH | 71989-16-7 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
90 | एच-असन (ट्रट) -ओएच | 132388-58-0 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
91 | Fmoc-Asp-OH | 119062-05-4 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
92 | एच-एएसपी (ओटीबीयू) -ओएच | 3057-74-7 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
93 | Fmoc-Cys-OH | 135248-89-4 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
94 | H-Cys(Trt)-OH | 2799/7/7 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
95 | H-Cys(Acm)-OH.HCl | 28798-28-9 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
96 | Fmoc-Gln-OH | 71989-20-3 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
97 | एच-ग्लन (टीआरटी) -ओएच | 102747-84-2 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
98 | Fmoc-ग्लू-OH | 121343-82-6 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
99 | एच-ग्लू (ओटीबीयू)-ओएच.एच2ओ | 2419-56-9 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
100 | Fmoc-उसका-OH | 116611-64-4 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
101 | H-उसका (Trt)-OH | 35146-32-8 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
102 | बोक-उसका-ओह | 17791-52-5 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
103 | Fmoc-Lys-OH | 105047-45-8 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
104 | एच-लिस (बीओसी) -ओएच | 2418-95-3 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
105 | एच-लिस (आवंटन) -ओएच | 6298/3/9 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
106 | Fmoc-Orn-OH.HCl | 201046-57-3 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
107 | एच-ओर्न (बीओसी) -ओएच | 13650-49-2 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
108 | Fmoc-सेर-OH | 73724-45-5 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
109 | एच-सेर (टीबीयू) -ओएच | 18822-58-7 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
110 | एच-सेर (टीआरटी) -ओएच | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
111 | Fmoc-Thr-OH.H2O | 73731-37-0 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
112 | एच-थ्र (टीबीयू) -ओएच | 4378-13-6 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
113 | Fmoc-Trp-OH | 35737-15-6 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
114 | एच-टीआरपी (बीओसी) -ओएच | 146645-63-8 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
115 | Fmoc-D-Trp-OH | 86123-11-7 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
116 | एचडी-टीआरपी (बीओसी) -ओएच | 201290-11-1 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
117 | Fmoc-Tyr-OH | 92954-90-0 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
118 | एच-टायर (टीबीयू) -ओएच | 18822-59-8 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
119 | Fmoc-D-Tyr-OH | 112883-29-1 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
120 | एचडी-टायर (एट) -ओएच | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
121 | एच-टायर(मी)-ओएच.एचसीएल | 67423-44-3 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
122 | Fmoc-D-4Aph (Cbm)-OH | 324017-22-3 | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
123 | HD-4Aph (tBuCbm)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
124 | Fmoc-Lys(iPr)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
125 | H-Lys(iPr,Boc)-OH | NA | 98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
मुआवज़ा
Gentolex उत्कृष्ट गुणवत्ता वाले उत्पाद प्रदान करता है, यदि किसी उत्पाद की गुणवत्ता क्लाइंट द्वारा आवश्यक समय सीमा के भीतर पर्याप्त सबूतों के साथ उठाई जाती है, तो हम मुआवजे की प्रक्रियाओं को ट्रिगर करने के लिए आवश्यक विश्लेषण और मूल्यांकन प्रदान करेंगे।
उत्पादन
फार्मास्युटिकल उत्पादों की क्षमता टन ग्रेड तक पहुंच गई, रासायनिक उत्पादों की क्षमता 100 टन + ग्रेड तक पहुंच गई, क्षमताएं दुनिया भर में ग्राहकों की सेवा करने के लिए अच्छी तरह से सुसज्जित हैं।
अनुसंधान और विकास
हर साल, विभिन्न नए उत्पादों को विकसित करने के लिए आर एंड डी टीम द्वारा योजना बनाई जाती है, जब लक्ष्य निर्धारित किया जाता है, तो टीम के प्रत्येक सदस्य को केपीआई जिम्मेदारी और प्रोत्साहन नीति के साथ आगे बढ़ना होगा।